Timeline

Blackrock Neurotech

10 dated events on the record · 8 primary-source · 0 contradictions · 2004–2026

Stated positionsVotesTransactionsContradictionsOther facts · Primary Secondary Inferential
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 STATED POSITIONS VOTES TRANSACTIONS CONTRADICTIONS OTHER FACTS
Recent events
2026-05-08 Other facts PRIMARY The MoveAgain system, designed for home use, remains in the FDA pre-market approval (PMA) pathway as of May 2026; despite earlier company projections for commercial availability in 2023, no public announcement of full…
2026-02-25 Other facts PRIMARY CFO Nathan Smith departed Blackrock Neurotech in August 2025 to join CareDx as CFO; he subsequently resigned from CareDx for personal reasons effective February 25, 2026.
2024-08-16 Other facts PRIMARY In August 2024, Blackrock Neurotech announced it had successfully restored the voice of an ALS patient using its BCI-to-text-to-speech interface, a project supported by the 2024 Tether capital infusion.
2024-04-29 Transactions SECONDARY In April 2024, the stablecoin issuer Tether invested $200 million via its Tether Evo venture arm to acquire a majority stake in Blackrock Neurotech.
2024-04-29 Transactions PRIMARY Tether (via Tether Evo) acquired a majority stake in April 2024 for $200 million. In June 2025, Tether CEO Paolo Ardoino stated the company needed a name change to avoid confusion with BlackRock Inc. and expressed…
2023-02-23 Other facts SECONDARY Blackrock Neurotech filed filing with the SEC on 2023-02-23. Accession number: N/A.
2021-06-15 Other facts PRIMARY The company's core technology, the Utah Array (also known as the NeuroPort Electrode), received Breakthrough Device Designation from the FDA in 2021 for its MoveAgain system.
2021-05-19 Transactions PRIMARY In May 2021, Blackrock Neurotech closed a $10 million financing round led by Christian Angermayer's re.Mind Capital, with participation from Peter Thiel and the University Venture Fund II.
2008-06-15 Other facts PRIMARY Blackrock Neurotech was founded in Salt Lake City in 2008 by Marcus Gerhardt (CEO) and Florian Solzbacher (Chairman), a professor at the University of Utah.
2004-06-15 Other facts PRIMARY The company's core technology, the Utah Array, was cleared by the FDA in 2004 for temporary (≤30 days) monitoring; it is the most implanted invasive BCI platform, with over 30,000 cumulative days of human implant data…